Portland Business Journal
April 09, 2024
Posted alongside a list that names OHSU as Oregon’s top NIH-funded institution, a Portland Business Journal story features the NIH-supported work of Steven Mansoor, M.D., Ph.D., to better understand how drugs work at the molecular level. If his team learns the structures of cell receptors associated with chronic inflammation, that information can help design drugs that adjust how the receptors work. Mansoor says: “The reason I find the current work so exciting is if we find a drug that can slow down or block atherosclerosis, that will make a tremendous impact.”